Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) Sees Significant Growth in Short Interest

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) was the recipient of a significant growth in short interest in the month of January. As of January 30th, there was short interest totaling 172,947 shares, a growth of 19.9% from the January 15th total of 144,184 shares. Based on an average trading volume of 68,792 shares, the days-to-cover ratio is presently 2.5 days. Based on an average trading volume of 68,792 shares, the days-to-cover ratio is presently 2.5 days.

Neonc Technologies Price Performance

NASDAQ NTHI opened at $8.98 on Thursday. The firm has a 50-day moving average price of $9.09 and a 200 day moving average price of $8.87. Neonc Technologies has a 52-week low of $3.20 and a 52-week high of $25.00.

Insider Buying and Selling

In other Neonc Technologies news, President Amir F. Heshmatpour bought 6,000 shares of the company’s stock in a transaction dated Monday, November 24th. The shares were purchased at an average cost of $6.51 per share, for a total transaction of $39,060.00. Following the transaction, the president directly owned 2,992,000 shares of the company’s stock, valued at approximately $19,477,920. The trade was a 0.20% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in NTHI. HighPoint Advisor Group LLC raised its stake in shares of Neonc Technologies by 424.8% during the third quarter. HighPoint Advisor Group LLC now owns 950,232 shares of the company’s stock valued at $8,628,000 after purchasing an additional 769,163 shares during the period. Bank of America Corp DE acquired a new stake in Neonc Technologies during the 2nd quarter valued at $801,000. Vanguard Group Inc. purchased a new stake in Neonc Technologies during the 3rd quarter worth $1,279,000. 683 Capital Management LLC purchased a new stake in Neonc Technologies during the 4th quarter worth $442,000. Finally, Global Retirement Partners LLC acquired a new position in Neonc Technologies in the 3rd quarter worth $434,000.

Analyst Upgrades and Downgrades

A number of research firms have commented on NTHI. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neonc Technologies in a research report on Monday, December 29th. Zacks Research raised shares of Neonc Technologies to a “hold” rating in a research note on Wednesday, January 14th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Neonc Technologies has a consensus rating of “Reduce”.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.